Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Intralesional triamcinolone acetonide is preferred for treating patchy alopecia areata due to fewer side effects.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Baricitinib is an effective treatment for severe alopecia areata.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

The hepatitis B vaccine did not cause hair loss in the tested mice.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.